Which feature distinguishes ketorolac from most other NSAIDs and dictates its prescribing restrictions?
- A It has strong anti-inflammatory activity but weak analgesic activity, limiting use to rheumatoid arthritis
- B It undergoes exclusively biliary excretion, making it safe in renal impairment
- C It is a selective COX-2 inhibitor suitable for long-term osteoarthritis therapy
- D It is a potent analgesic comparable to low-dose opioids, but parenteral or oral use must not exceed five days because of gastrointestinal bleeding and renal risks ✓
Explanation
Ketorolac is unusual among NSAIDs in having analgesic potency comparable to modest opioid doses, which led to its use for postoperative pain, but its toxicity profile mandates strict limits: treatment should not exceed five days, with gastrointestinal haemorrhage and renal impairment being the chief concerns. It is a non-selective COX inhibitor, not a coxib, and it is renally excreted, so it is avoided in significant kidney disease.
Reference: Katzung Basic and Clinical Pharmacology, 15th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.